Cargando…

53 The development of a multi-institutional prospective registry for patients with metastatic invasive lobular carcinoma: identifying new markers of disease progression – CORRIGENDUM

Detalles Bibliográficos
Autores principales:	Rothschild, Harriet T, Jo Chien, A, Jankowitz, Rachel C, Magbanua, Mark JM, Mouabbi, Jason A, Shatsky, Rebecca A, Levine, Julia, Mukhtar, Rita A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2023
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10565189/ https://www.ncbi.nlm.nih.gov/pubmed/37830005 http://dx.doi.org/10.1017/cts.2023.637

Ejemplares similares

53 The development of a multi-institutional prospective registry for patients with metastatic invasive lobular carcinoma: identifying new markers of disease progression
por: Rothschild, Harriet, et al.
Publicado: (2023)

HER-2 low status in early-stage invasive lobular carcinoma of the breast: associated factors and outcomes in an institutional series
por: Rothschild, Harriet T., et al.
Publicado: (2023)

Quantifying hormone receptor status in lobular breast cancer in an institutional series: the relationship between estrogen and progesterone receptor status and outcomes
por: Clelland, Elle N., et al.
Publicado: (2023)

The impact of histologic subtype on primary site surgery in the management of metastatic lobular versus ductal breast cancer: a population based study from the National Cancer Database
por: Rothschild, Harriet T, et al.
Publicado: (2023)

Tamoxifen or aromatase inhibitors with ovarian function suppression in pre-menopausal stage I-III lobular breast cancer
por: Record, Helena, et al.
Publicado: (2023)

Corrigendum to ‘Understanding p53 functions through p53 antibodies’
por: Sabapathy, Kanaga, et al.
Publicado: (2019)

Corrigendum to “Role of Magnetic Resonance Imaging in the Preoperative Staging and Work-Up of Patients Affected by Invasive Lobular Carcinoma or Invasive Ductolobular Carcinoma”
por: Selvi, Valeria, et al.
Publicado: (2018)

Successful Breast Conservation After Neoadjuvant Chemotherapy in Lobular Breast Cancer: The Role of Menopausal Status in Response to Treatment
por: Ramalingam, Kirithiga, et al.
Publicado: (2023)

Obesity and menopausal status impact the features and molecular phenotype of invasive lobular breast cancer
por: Rothschild, Harriet T., et al.
Publicado: (2021)

Corrigendum to ‘p53 balances between tissue hierarchy and anarchy’
por: Koifman, Gabriela, et al.
Publicado: (2019)

Predictors of Early Versus Late Recurrence in Invasive Lobular Carcinoma of the Breast: Impact of Local and Systemic Therapy
por: Rothschild, Harriet T., et al.
Publicado: (2023)

Corrigendum. ART in Europe, 2015: results generated from European registries by ESHRE
por: De Geyter, C, et al.
Publicado: (2020)

Spatial patterning and correlates of self-harm in Manchester, England – CORRIGENDUM
por: Lin, Chien-Yu, et al.
Publicado: (2020)

Area Deprivation Index in Patients with Invasive Lobular Carcinoma of the Breast: Associations with Tumor Characteristics and Outcomes
por: Kaur, Mandeep, et al.
Publicado: (2023)

Lobular Carcinoma of the Breast: A Comprehensive Review with Translational Insights
por: Batra, Harsh, et al.
Publicado: (2023)

The efficacy and safety of apatinib in metastatic alveolar soft part sarcoma: a case series of six patients in one institution [Corrigendum]
Publicado: (2019)

Corrigendum to: Changes in oral anticoagulation for elective cardioversion: results from a European cardioversion registry
Publicado: (2018)

Corrigendum to “Breast Cancer Survival and Incidence: 10 Years Cancer Registry Data in the Northwest, Iran”
por: Dolatkhah, Roya, et al.
Publicado: (2021)

Transcervical Radiofrequency Ablation of Uterine Fibroids Global Registry (SAGE): Study Protocol and Preliminary Results [Corrigendum]
Publicado: (2021)

Oral Maintenance Chemotherapy Using S-1/Capecitabine in Metastatic Nasopharyngeal Carcinoma Patients After Systemic Chemotherapy: A Single-Institution Experience [Corrigendum]
Publicado: (2020)

Corrigendum to “DNA methylation markers for oral pre-cancer progression: A critical review” [Oral Oncology 53 (2015) 1–9]
por: Shridhar, Krithiga, et al.
Publicado: (2016)

Corrigendum to: Venous thromboembolism in cancer patients: report of baseline data from the multicentre, prospective Cancer-VTE Registry
por: Ohashi, Yasuo, et al.
Publicado: (2020)

Corrigendum to: Outcomes of culture-negative vs. culture-positive infective endocarditis: the ESC-EORP EURO-ENDO registry
Publicado: (2023)

Corrigendum
por: Dontas, Anastasios S, et al.
Publicado: (2008)

Overexpression of RNF126 Promotes the Development of Colorectal Cancer via Enhancing p53 Ubiquitination and Degradation [Corrigendum]
Publicado: (2021)

Corrigendum to: Digoxin use in contemporary heart failure with reduced ejection fraction: An analysis from the Swedish Heart Failure Registry
Publicado: (2023)

Corrigendum to: Data standards for heart failure: the European Unified Registries for Heart Care Evaluation and Randomized Trials (EuroHeart)
Publicado: (2023)

Corrigendum to “Prognostic Effect of Long Noncoding RNA NEAT1 Expression Depends on p53 Mutation Status in Cancer”
por: Idogawa, Masashi, et al.
Publicado: (2019)

20(S)-Ginsenoside Rg3 Promotes Senescence And Apoptosis In Gallbladder Cancer Cells Via The P53 Pathway [Corrigendum]
Publicado: (2019)

Corrigendum to “Cellular redox imbalance on the crossroad between mitochondrial dysfunction, senescence, and proliferation” [Redox Biol. 53 (2022) 102337]
por: Bakalova, Rumiana, et al.
Publicado: (2022)

Developing a Registry of Healthcare-Associated Infections at Intensive Care Units in West China: Study Rationale and Patient Characteristics [Corrigendum]
Publicado: (2020)

Prevalence and Antibiotic Susceptibility of the Common Bacterial Uropathogen Among UTI Patients in French Medical Institute for Children [Corrigendum]
Publicado: (2022)

Taxanes in the elderly patient with metastatic breast cancer [Corrigendum]
Publicado: (2019)

Corrigendum to “Feline mammary carcinoma stem cells are tumorigenic, radioresistant, chemoresistant and defective in activation of the ATM/p53 DNA damage pathway” [The Veterinary Journal 196 (2013) 414–423]
por: Pang, L.Y., et al.
Publicado: (2021)

Corrigendum to ‘A More Fitting Approach to Mask Policy’ The American Journal of Medicine, Volume 135, Issue 11 (2022) 1280-1281
por: Levine, Marc
Publicado: (2023)

Summarizing and Communicating on Survival Data According to the Audience: A Tutorial on Different Measures Illustrated with Population-Based Cancer Registry Data [Corrigendum]
Publicado: (2020)

Corrigendum to: Data standards for transcatheter aortic valve implantation: the European Unified Registries for Heart Care Evaluation and Randomised Trials (EuroHeart)
Publicado: (2022)

An international multi-site, randomized controlled trial of a mindfulness-based psycho-education group program for people with schizophrenia – CORRIGENDUM
por: Chien, W. T., et al.
Publicado: (2023)

Corrigendum to “Cutaneous Plasmacytosis with Perineural Involvement”
por: Brezinski, Elizabeth A., et al.
Publicado: (2016)

Decreased enrollment in breast cancer trials by histologic subtype: does invasive lobular carcinoma resist RECIST?
por: Abel, Mary Kathryn, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_l9j98esm94c09iebimlfq4g16s